Marco Pirisinu: Highlights Potential of PDEVs in Drug Delivery
Marco Pirisinu, Director of Business Development at Jotbody, shared a post on LinkedIn:
“Hey everyone,
I recently came across a review discussing the potential of plant-derived extracellular vesicles (PDEVs) in drug delivery.
Some highlights:
• Natural Carriers: PDEVs naturally encapsulate bioactive molecules like proteins, lipids, and RNAs, which can synergize with therapeutic agents.
• Biocompatibility: Being plant-based, they exhibit low immunogenicity, reducing potential adverse reactions.
• Stability: PDEVs demonstrate resilience under various conditions, ensuring the integrity of encapsulated drugs.
• Scalability: Plants offer a sustainable and scalable source for vesicle production, facilitating large-scale applications.
These attributes make PDEVs a promising avenue for delivering a range of therapeutic agents, including small molecules, proteins, and nucleic acids.
I will also put the reference here“.
All the latest news in the World of Hematology featured in Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies